Drug costs in context: assessing drug costs in cost-of-illness analyses

Cost-of-illness (COI) studies attempt to measure and describe the costs associated or attributed to a specific disease, but there are several considerations for measuring and interpreting drug costs estimates. The complexity of the pharmaceutical supply chain and contractual relationships between ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattingly, T Joseph, Weathers, Shannon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333414/
https://www.ncbi.nlm.nih.gov/pubmed/35949272
http://dx.doi.org/10.7573/dic.2022-5-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333414/
https://www.ncbi.nlm.nih.gov/pubmed/35949272
http://dx.doi.org/10.7573/dic.2022-5-4

Ejemplares similares